Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG4010 in stage IV NSCLC (TIME study)
NCT01383148Phase 3Terminated
- Sponsor
- Transgene SA
- Start
- Apr 2012
- Primary completion
- Jul 2015
- Countries
- 10
01
Overview
A Phase 3 trial of TG4010 in non-small cell lung cancer (NSCLC), sponsored by Transgene SA. Started Apr 2012; status: terminated.
02
Drugs
TG4010
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01383148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01383148.